JACQUELYN L. SUMER - 17 Feb 2023 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role: Chief Legal Officer
Signature: /s/ Jacquelyn Sumer
Issuer symbol: CGEM
Transactions as of: 17 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 21 Feb 2023, 17:54:54 UTC
Previous filing: 16 Aug 2022
Next filing: 27 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CGEM	Common Stock	Award	$0	+47,000		$0.000000	47,000	17 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CGEM	Stock Option (Right to Buy)	Award	$0	+93,500		$0.000000	93,500	17 Feb 2023	Common Stock	93,500	$11.34	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
F2	The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.